EU seeks feedback: What direction should European life sciences take?

The European Union is calling for dialogue, inviting citizens, businesses and researchers to help shape the future of Europe's life sciences. The EU has set out its vision in a new policy paper - now the public is being asked to have their say.

Life sciences' is a collective term for scientific disciplines that deal with living organisms. It includes biology, medicine, biotechnology, pharmacy, genetics and related fields. The aim of the life sciences is to understand life in all its facets and to make this knowledge useful for medicine, environmental and nutritional sciences and biotechnology.

Research with vision 

The heart of the proposal: Europe should secure its position as a leading location for life sciences innovation. Key areas are personalised medicine, biotechnology and sustainability in the pharmaceutical industry. The emphasis is on competitiveness, ethical responsibility and international cooperation.

What is at stake?

The life sciences are a multi-billion euro market that is vital for health and the economy. But Europe risks falling behind in global competition. High regulatory hurdles, lengthy approval procedures and a complex funding environment are slowing down innovation. The EU Commission wants to tackle this by improving the conditions for start-ups and investment in new technologies.

Your opinion counts!

Interested parties can submit their suggestions until 17 April 2025. All feedback will be taken into account in the final strategy. Take this opportunity to shape the future of Europe's life sciences!